NCT02078180View on ClinicalTrials.gov

Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Depression
Interventions
DRUG

generic bupropion

We are comparing different formulations of bupropion that release this drug at different rates. The abbreviation IR75 means immediate release and the number is the dose in mg. The other abbreviations represent SR for sustained-release and XL for extended release, which release the drug slower than the IR formulation.

Trial Locations (1)

48109-2700

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT02078180 - Pharmacokinetic Study of Bupropion Hydrochloride Products With Different Release Patterns | Biotech Hunter | Biotech Hunter